These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 24628287)
1. Lanthionine synthetase component C-like protein 2: a new drug target for inflammatory diseases and diabetes. Lu P; Hontecillas R; Philipson CW; Bassaganya-Riera J Curr Drug Targets; 2014 Jun; 15(6):565-72. PubMed ID: 24628287 [TBL] [Abstract][Full Text] [Related]
2. Computational modeling-based discovery of novel classes of anti-inflammatory drugs that target lanthionine synthetase C-like protein 2. Lu P; Hontecillas R; Horne WT; Carbo A; Viladomiu M; Pedragosa M; Bevan DR; Lewis SN; Bassaganya-Riera J PLoS One; 2012; 7(4):e34643. PubMed ID: 22509338 [TBL] [Abstract][Full Text] [Related]
3. Identification of a high affinity binding site for abscisic acid on human lanthionine synthetase component C-like protein 2. Cichero E; Fresia C; Guida L; Booz V; Millo E; Scotti C; Iamele L; de Jonge H; Galante D; De Flora A; Sturla L; Vigliarolo T; Zocchi E; Fossa P Int J Biochem Cell Biol; 2018 Apr; 97():52-61. PubMed ID: 29421190 [TBL] [Abstract][Full Text] [Related]
4. Binding of abscisic acid to human LANCL2. Sturla L; Fresia C; Guida L; Grozio A; Vigliarolo T; Mannino E; Millo E; Bagnasco L; Bruzzone S; De Flora A; Zocchi E Biochem Biophys Res Commun; 2011 Nov; 415(2):390-5. PubMed ID: 22037458 [TBL] [Abstract][Full Text] [Related]
5. Molecular modeling of lanthionine synthetase component C-like protein 2: a potential target for the discovery of novel type 2 diabetes prophylactics and therapeutics. Lu P; Bevan DR; Lewis SN; Hontecillas R; Bassaganya-Riera J J Mol Model; 2011 Mar; 17(3):543-53. PubMed ID: 20512604 [TBL] [Abstract][Full Text] [Related]
6. An N,N-Bis(benzimidazolylpicolinoyl)piperazine (BT-11): A Novel Lanthionine Synthetase C-Like 2-Based Therapeutic for Inflammatory Bowel Disease. Carbo A; Gandour RD; Hontecillas R; Philipson N; Uren A; Bassaganya-Riera J J Med Chem; 2016 Nov; 59(22):10113-10126. PubMed ID: 27933891 [TBL] [Abstract][Full Text] [Related]
7. LANCL2 is necessary for abscisic acid binding and signaling in human granulocytes and in rat insulinoma cells. Sturla L; Fresia C; Guida L; Bruzzone S; Scarfì S; Usai C; Fruscione F; Magnone M; Millo E; Basile G; Grozio A; Jacchetti E; Allegretti M; De Flora A; Zocchi E J Biol Chem; 2009 Oct; 284(41):28045-28057. PubMed ID: 19667068 [TBL] [Abstract][Full Text] [Related]
8. New Insights into the LANCL2- Scarano N; Di Palma F; Origlia N; Musumeci F; Schenone S; Spinelli S; Passalacqua M; Zocchi E; Sturla L; Cichero E; Cavalli A Pharmaceutics; 2023 Dec; 15(12):. PubMed ID: 38140095 [TBL] [Abstract][Full Text] [Related]
10. Myristoylation of human LanC-like protein 2 (LANCL2) is essential for the interaction with the plasma membrane and the increase in cellular sensitivity to adriamycin. Landlinger C; Salzer U; Prohaska R Biochim Biophys Acta; 2006 Nov; 1758(11):1759-67. PubMed ID: 16979580 [TBL] [Abstract][Full Text] [Related]
11. Lanthionine Synthetase C-Like 2 Modulates Immune Responses to Influenza Virus Infection. Leber A; Bassaganya-Riera J; Tubau-Juni N; Zoccoli-Rodriguez V; Lu P; Godfrey V; Kale S; Hontecillas R Front Immunol; 2017; 8():178. PubMed ID: 28270815 [TBL] [Abstract][Full Text] [Related]
12. G-protein coupling and nuclear translocation of the human abscisic acid receptor LANCL2. Fresia C; Vigliarolo T; Guida L; Booz V; Bruzzone S; Sturla L; Di Bona M; Pesce M; Usai C; De Flora A; Zocchi E Sci Rep; 2016 May; 6():26658. PubMed ID: 27222287 [TBL] [Abstract][Full Text] [Related]
14. Treating Autoimmune Diseases With LANCL2 Therapeutics: A Novel Immunoregulatory Mechanism for Patients With Ulcerative Colitis and Crohn's Disease. Tubau-Juni N; Hontecillas R; Leber AJ; Alva SS; Bassaganya-Riera J Inflamm Bowel Dis; 2024 Apr; 30(4):671-680. PubMed ID: 37934790 [TBL] [Abstract][Full Text] [Related]
15. Abscisic acid signaling through LANCL2 and PPARγ induces activation of p38MAPK resulting in dormancy of prostate cancer metastatic cells. Parajuli KR; Jung Y; Taichman RS Oncol Rep; 2024 Mar; 51(3):. PubMed ID: 38624012 [TBL] [Abstract][Full Text] [Related]
16. Autocrine abscisic acid mediates the UV-B-induced inflammatory response in human granulocytes and keratinocytes. Bruzzone S; Basile G; Mannino E; Sturla L; Magnone M; Grozio A; Salis A; Fresia C; Vigliarolo T; Guida L; De Flora A; Tossi V; Cassia R; Lamattina L; Zocchi E J Cell Physiol; 2012 Jun; 227(6):2502-10. PubMed ID: 21898394 [TBL] [Abstract][Full Text] [Related]
17. Abscisic acid enhances glucose disposal and induces brown fat activity in adipocytes in vitro and in vivo. Sturla L; Mannino E; Scarfì S; Bruzzone S; Magnone M; Sociali G; Booz V; Guida L; Vigliarolo T; Fresia C; Emionite L; Buschiazzo A; Marini C; Sambuceti G; De Flora A; Zocchi E Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Feb; 1862(2):131-144. PubMed ID: 27871880 [TBL] [Abstract][Full Text] [Related]
18. Lanthionine synthetase components C-like 2 increases cellular sensitivity to adriamycin by decreasing the expression of P-glycoprotein through a transcription-mediated mechanism. Park S; James CD Cancer Res; 2003 Feb; 63(3):723-7. PubMed ID: 12566319 [TBL] [Abstract][Full Text] [Related]
19. Functional characterization of a synthetic abscisic acid analog with anti-inflammatory activity on human granulocytes and monocytes. Grozio A; Millo E; Guida L; Vigliarolo T; Bellotti M; Salis A; Fresia C; Sturla L; Magnone M; Galatini A; Damonte G; De Flora A; Bruzzone S; Bagnasco L; Zocchi E Biochem Biophys Res Commun; 2011 Dec; 415(4):696-701. PubMed ID: 22086172 [TBL] [Abstract][Full Text] [Related]
20. Autocrine abscisic acid plays a key role in quartz-induced macrophage activation. Magnone M; Sturla L; Jacchetti E; Scarfì S; Bruzzone S; Usai C; Guida L; Salis A; Damonte G; De Flora A; Zocchi E FASEB J; 2012 Mar; 26(3):1261-71. PubMed ID: 22042223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]